Arcturus Therapeutics (ARCT) PT Lowered to $45 at Guggenheim
Tweet Send to a Friend
(Updated - April 10, 2025 7:08 AM EDT)
Guggenheim analyst Whitney Ijem lowered the price target on Arcturus Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Whitney Ijem lowered the price target on Arcturus Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
